Genoskin

Series-A
genoskin.com Biotech & Healthcare
Total Funding $8.7M
Latest Round $8.7M Series-A
Last Announced Sep 16, 2025
Investors Undisclosed
Decision Makers 5 Available

About Genoskin

Genoskin's ex vivo human skin models stay immunocompetent for upto 10 days in culture, generating reliable human data before clinical trials.

Sectors & Market Categories

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-A
Global Headquarters Undisclosed
Tracked Since Nov 8, 2026

Web & Domain Identity

Official Website genoskin.com
Domain Registered Date Undisclosed

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Company Profile

Company Milestones & Timeline

1 Events
  1. Capital Raise

    Raised $8,700,000 · Series-A

    fundraisingfox.com

Investors & Backers

Investor firms and individual backers were not publicly disclosed in available round filings for Genoskin.

Funding History

1 Round
Series-A equity · Sep 16, 2025

Founders & Leadership

1

Pascal Descargues

Founder

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

Recently funded startups
New SaaS launches
Never pay twice for contacts